Cleared Special

K211594 - Trevo Trak 21 Microcatheter

K211594 is the FDA 510(k) clearance for Trevo Trak 21 Microcatheter by Stryker Neurovascular. It is a Class 2 Neurology device (product code QJP) cleared through the Special 510(k) pathway after a 186-day FDA review.

K211594 · Stryker Neurovascular · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2021
Decision
186d
Days
Class 2
Risk

K211594 is an FDA 510(k) clearance for the Trevo Trak 21 Microcatheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on November 26, 2021 after a review of 186 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Stryker Neurovascular devices

Submission Details

510(k) Number K211594 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2021
Decision Date November 26, 2021
Days to Decision 186 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 148d · This submission: 186d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K211594.
EMBOGUARD Balloon Guide Catheter
K212340 · Neuravi Limited · Dec 2021
MIVI Q Distal Access Catheter
K212402 · Mivi Neuroscience, Inc. · Dec 2021
Branchor Balloon Guide Catheter
K203723 · Asahi Intecc Co., Ltd. · Dec 2021
Spartan MC 0165
K213451 · Spartan Micro · Nov 2021
TracStar LDP Large Distal Platform
K212224 · Imperative Care, Inc. · Sep 2021
AXS Vecta 46 Intermediate Catheter
K202752 · Stryker Neurovascular · Aug 2021